434 results
Page 2 of 22
SC TO-C
EX-99.1
3xrye1zg0 z3yes0t0rj
3 Oct 23
Information about tender offer
4:30pm
SC TO-T/A
EX-99
fd7py9fckdyd87g yin
9 Aug 23
Third party tender offer statement (amended)
9:14am
8-K
EX-99.1
c875qxcxnf34ys
8 Aug 23
Lilly Reports Second-Quarter 2023 Financial Results, Highlights Accelerating Revenue Growth and Key Pipeline Advancements
7:01am
SC TO-T/A
EX-99
g54qzpxv
25 Jul 23
Third party tender offer statement (amended)
7:04am
SC TO-T
EX-99
1jpojdx
13 Jul 23
Third party tender offer statement
8:01am
SC TO-T
EX-99
qbvhv8zy 99dd
30 Jun 23
Third party tender offer statement
4:06pm
SC TO-C
EX-99.1
0v57c43e
29 Jun 23
Information about tender offer
6:56am
SC TO-C
EX-99.1
mbhwx og11
20 Jun 23
Information about tender offer
8:20am
8-K
EX-99.01
1ej90yxidft0 ssgh
27 Apr 23
Results of Operations and Financial Condition
7:02am
PX14A6G
7z0plup8s7u489bscdf
21 Apr 23
Letter to shareholders
2:02pm
PX14A6G
bg77puk
4 Apr 23
Letter to shareholders
3:57pm
8-K
EX-99
v21p3gf
13 Dec 22
Lilly Announces 2023 Financial Guidance, Plans to Launch up to Four New Medicines
7:03am
SC TO-T/A
EX-99
pkbich0ctprcp
30 Nov 22
Third party tender offer statement (amended)
6:58am
8-K
EX-99.1
mejbjs0ituh4pv
1 Nov 22
Lilly Reports Solid Third-Quarter 2022 Financial Results and Continued Pipeline Progress
7:03am